Results 181 to 188 of about 10,088 (188)
Some of the next articles are maybe not open access.

H56 Huntington disease as a risk factor for offspring’s well-being

H: Clinical care and clinical services, 2022
Sabrina Maffi   +5 more
openaire   +1 more source

Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

The Lancet Infectious Diseases
People with tuberculosis who complete treatment remain at risk of recurrent disease. The vaccine H56:IC31 has been shown to be safe and immunogenic in phase 1 and 2 studies, but whether it can reduce the risk of tuberculosis recurrence is unknown.In a double-blind, randomised, placebo-controlled, phase 2b trial in South Africa (five clinical trial ...
Álvaro H Borges   +185 more
openaire   +2 more sources

Nuclear magnetic resonance data of C28 H56

2010
H.-O. Kalinowski   +3 more
openaire   +1 more source

Hemodynamic effects of alprenolol (H56-28).

Archives internationales de pharmacodynamie et de therapie, 1971
J D, Proctor, F J, Allen, A J, Wasserman
openaire   +1 more source

[The use of the beta-adrenergic blocking agent H56-28 in arrhythmias].

Archivos del Instituto de Cardiologia de Mexico, 1969
M, Cárdenas   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy